Royalty Pharma ^Investor

Royalty Pharma is the world's largest buyer of biopharmaceutical royalties and a leading funder of innovation in life sciences. They have a unique business model that involves acquiring revenue-producing intellectual property, specifically royalty interests in marketed and late-stage development biopharmaceutical products. They provide liquidity to royalty owners and assume the future risks and rewards of ownership. With over 60% global market share, Royalty Pharma is the leading partner in funding innovation in the life sciences industry. They have a strong track record of success, owning royalty interests in numerous approved and marketed biopharmaceutical products, as well as products in clinical trials and under review with regulatory agencies.